表紙
市場調査レポート

大動脈弁狭窄症:世界の治験レビュー

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 167023
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
大動脈弁狭窄症:世界の治験レビュー Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014
出版日: 2014年08月12日 ページ情報: 英文 71 Pages
概要

当レポートでは、大動脈弁狭窄症に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 大動脈弁狭窄症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカにおける治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:心血管系疾病の治験件数に対する大動脈弁狭窄症の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:心血管系疾病の治験件数に対する大動脈弁狭窄症の治験件数比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験概要
    • Edwards Lifesciences Corporation
    • CryoLife, Inc.
    • AstraZeneca PLC
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Direct Flow Medical, Inc.
    • Cerenis Therapeutics SA
    • A. Menarini Industrie Farmaceutiche Riunite Srl
  • 代表的な研究機関・病院の治験の概要
    • National Heart, Lung, and Blood Institute
    • Erasmus MC
    • Assistance Publique - Hopitaux de Paris
    • Washington University School of Medicine
    • Charles University
    • University of Edinburgh
    • Asan Medical Center
    • Helsinki University Central Hospital
    • Aarhus University Hospital
    • Sahlgrenska University Hospital

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Aortic Valve Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Valve Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Valve Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aortic Valve Stenosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aortic Valve Stenosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aortic Valve Stenosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Edwards Lifesciences Corporation
      • Clinical Trial Overview of Edwards Lifesciences Corporation
      • CryoLife, Inc.
      • Clinical Trial Overview of CryoLife, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Direct Flow Medical, Inc.
      • Clinical Trial Overview of Direct Flow Medical, Inc.
      • Cerenis Therapeutics SA
      • Clinical Trial Overview of Cerenis Therapeutics SA
      • A. Menarini Industrie Farmaceutiche Riunite Srl
      • Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • Charles University
      • Clinical Trial Overview of Charles University
      • University of Edinburgh
      • Clinical Trial Overview of University of Edinburgh
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
      • Helsinki University Central Hospital
      • Clinical Trial Overview of Helsinki University Central Hospital
      • Aarhus University Hospital
      • Clinical Trial Overview of Aarhus University Hospital
      • Sahlgrenska University Hospital
      • Clinical Trial Overview of Sahlgrenska University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Edwards Lifesciences Corporation, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Flow Medical, Inc., 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cerenis Therapeutics SA, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2014*

List of Figures

  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top